TBXT and inflammatory bowel disease: The results showed that in the low-risk score group, “intestinal immune network for IgA production,” “Th17 cell differentiation,” “B cell receptor signaling pathway,” “T cell receptor signaling pathway,” and “inflammatory bowel disease” were significantly upregulated (Figure 5E).